Gary A Pestano
Overview
Explore the profile of Gary A Pestano including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
311
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
McDowell C, Weaver A, Vargas-Cruz N, Kaiser N, Nichols C, Pestano G
Biomedicines
. 2024 Oct;
12(10).
PMID: 39457630
Background: There is significant interest in developing alternatives to traditional blood transportation and separation methods, which often require centrifugation and cold storage to preserve specimen integrity. Here we provide new...
2.
McKelvey B, Andrews H, Baehner F, Chen J, Espenschied C, Fabrizio D, et al.
Diagnostics (Basel)
. 2024 May;
14(9).
PMID: 38732326
Circulating tumor DNA (ctDNA) holds promise as a biomarker for predicting clinical responses to therapy in solid tumors, and multiple ctDNA assays are in development. However, the heterogeneity in ctDNA...
3.
Koc M, Wiles T, Weinhold D, Rightmyer S, Weaver A, McDowell C, et al.
J Mass Spectrom Adv Clin Lab
. 2023 Dec;
30:51-60.
PMID: 38074293
Introduction: The VeriStrat® test (VS) is a blood-based assay that predicts a patient's response to therapy by analyzing eight features in a spectrum obtained from matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF)...
4.
Mercer T, Almond N, Crone M, Chain P, Deshpande A, Eveleigh D, et al.
Nat Biotechnol
. 2022 Nov;
40(11):1563-1568.
PMID: 36323792
No abstract available.
5.
Brunner W, Freilich D, Victory J, Krupa N, Scribani M, Jenkins P, et al.
Int J Infect Dis
. 2022 Aug;
123:183-191.
PMID: 36044963
Objectives: There are limited comparative immunologic durability data post COVID-19 vaccinations. Methods: Approximately 8.4 months after primary COVID-19 vaccination, 647 healthcare workers completed surveys about COVID-19 vaccinations/infections and blood draws....
6.
Windsor W, Roell Y, Tucker H, Cheng C, Suliman S, Peek L, et al.
Front Microbiol
. 2022 Jun;
13:893801.
PMID: 35707164
Background: There is an urgent need for harmonization between severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) serology platforms and assays prior to defining appropriate correlates of protection and as well...
7.
Jackson L, Tjoa B, Mellert H, Pestano G
Cancer Drug Resist
. 2022 May;
3(3):563-571.
PMID: 35582444
The aim of this study was to demonstrate the utility of T-Cell receptor beta (TCRβ) sequencing as a robust method for assessing T-cell repertoire changes in donors with non-small cell...
8.
Audetat A, Tschida C, Kreston S, Stephen A, DAlessio B, Bondy M, et al.
Diagnostics (Basel)
. 2022 Mar;
12(3).
PMID: 35328282
Liquid biopsies are an integral part of the diagnosis of cancer. Here, we have extended previous validation studies of a new targeted NGS panel to include the detection of copy...
9.
Mellert H, Reese J, Jackson L, Maxwell V, Tschida C, Pestano G
Diagnostics (Basel)
. 2021 Jan;
11(2).
PMID: 33494470
Liquid biopsy tests have become an integral part of the molecular diagnosis of patients with non-small cell lung cancer (NSCLC). We describe a new test panel that uses very low...
10.
Kaiser N, Steers M, Nichols C, Mellert H, Pestano G
Diagnostics (Basel)
. 2020 Dec;
10(12).
PMID: 33276497
A major hurdle for blood-based proteomic diagnostics is efficient transport of specimens from the collection site to the testing laboratory. Dried blood spots have shown utility for diagnostic applications, specifically...